Legal & General Group PLC Avidity Biosciences, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 121,814 shares of RNA stock, worth $8.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121,814

Previous 103,125 18.12%

Holding current value

$8.62 Million

Previous $2.93 Million 81.25%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$28.46 - $50.36 $531,888 - $941,178	18,689 Added 18.12%	121,814 $5.31 Million
Q2 2025 Aug 12, 2025	BUY	$24.08 - $36.24 $93,334 - $140,466	3,876 Added 3.91%	103,125 $2.93 Million
Q1 2025 May 15, 2025	SELL	$27.05 - $35.11 $77,119 - $100,098	-2,851 Reduced 2.79%	99,249 $2.93 Million
Q4 2024 Feb 13, 2025	BUY	$29.08 - $52.5 $201,727 - $364,192	6,937 Added 7.29%	102,100 $2.97 Million
Q3 2024 Feb 28, 2025	SELL	$37.21 - $48.14 $525,070 - $679,303	-14,111 Reduced 13.82%	87,989 $4.04 Million

Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $103,592 - $134,021	2,784 Added 3.01%	95,163 $4.37 Million
Q2 2024 May 29, 2025	BUY	$22.73 - $40.85 $208,115 - $374,022	9,156 Added 12.04%	85,205 $3.48 Million
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $371,180 - $667,080	16,330 Added 21.47%	92,379 $3.77 Million
Q1 2024 May 29, 2025	SELL	$9.16 - $25.52 $212,512 - $592,064	-23,200 Reduced 23.38%	76,049 $1.94 Million
Q1 2024 May 14, 2024	BUY	$9.16 - $25.52 $157,680 - $439,301	17,214 Added 29.26%	76,049 $1.94 Million
Q4 2023 May 29, 2025	SELL	$4.87 - $9.37 $196,816 - $378,679	-40,414 Reduced 40.72%	58,835 $532,000
Q4 2023 Feb 15, 2024	BUY	$4.87 - $9.37 $1,373 - $2,642	282 Added 0.48%	58,835 $532,000
Q3 2023 Nov 14, 2023	SELL	$6.3 - $11.35 $4,315 - $7,774	-685 Reduced 1.16%	58,553 $373,000
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $316,231 - $516,333	29,777 Added 101.07%	59,238 $656,000
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $111,916 - $187,014	7,291 Added 32.89%	29,461 $452,000
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $54,555 - $122,885	5,423 Added 32.38%	22,170 $491,000
Q3 2022 Nov 14, 2022	SELL	$15.46 - $23.43 $41,649 - $63,120	-2,694 Reduced 13.86%	16,747 $274,000
Q2 2022 Aug 22, 2022	BUY	$11.18 - $20.5 $8,105 - $14,862	725 Added 3.87%	19,441 $282,000
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $7,838 - $13,126	552 Added 3.04%	18,716 $345,000
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $269,730 - $374,444	14,853 Added 448.6%	18,164 $448,000
Q2 2021 Aug 12, 2021	SELL	$19.62 - $29.26 $11,575 - $17,263	-590 Reduced 15.12%	3,311 $82,000
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $25,532 - $35,440	1,259 Added 47.65%	3,901 $85,000
Q4 2020 Feb 12, 2021	BUY	$24.73 - $35.12 $19,066 - $27,077	771 Added 41.21%	2,642 $68,000
Q3 2020 Nov 13, 2020	BUY	$23.35 - $35.94 $43,687 - $67,243	1,871 New	1,871 $53,000

Others Institutions Holding RNA

# of Institutions

311

Shares Held

139M

Call Options Held

1.24M

Put Options Held

526K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $3.69B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Avidity Biosciences, Inc. Transaction History